skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies

Scientific reports, 2021-05, Vol.11 (1), p.10646-8, Article 10646 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-90175-w ;PMID: 34017024

Full text available

Citations Cited by
  • Title:
    Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies
  • Author: Aune, Dagfinn ; Sen, Abhijit ; Norat, Teresa ; Riboli, Elio ; Folseraas, Trine
  • Subjects: Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - epidemiology ; Cholangiocarcinoma ; Cholangitis ; Cholangitis, Sclerosing - complications ; Cholangitis, Sclerosing - mortality ; Cohort Studies ; Colorectal cancer ; Colorectal carcinoma ; Confidence Intervals ; Humans ; Liver cancer ; Medicin och hälsovetenskap ; Meta-analysis ; Mortality ; Neoplasms - epidemiology ; Pancreatic cancer ; Risk ; Risk assessment ; Risk Factors ; Systematic review
  • Is Part Of: Scientific reports, 2021-05, Vol.11 (1), p.10646-8, Article 10646
  • Description: A diagnosis of primary sclerosing cholangitis (PSC) has been associated with increased risk of hepatobiliary cancers, colorectal cancer and all-cause mortality in several studies, while associations with cardiovascular disease have been inconsistent. We conducted a systematic review and meta-analysis of published cohort studies on the topic to summarize these associations. PubMed and Embase databases were searched up to January 13th, 2020. Cohort studies on PSC and risk of cancer, cardiovascular disease, or mortality were included. Summary relative risks (RRs) and 95% confidence intervals (95% CIs) were estimated using random effects models. The summary RR (95% CI) comparing persons with PSC to persons without PSC was 584.37 (269.42-1267.51, I  = 89%, n = 4) for cholangiocarcinoma (CCA), 155.54 (125.34-193.02, I  = 0%, n = 3) for hepatobiliary cancer, 30.22 (11.99-76.17, I  = 0%, n = 2) for liver cancer, 16.92 (8.73-32.78, I  = 88%, n = 4) for gastrointestinal cancer, 7.56 (2.42-23.62, I  = 0%, n = 3) for pancreatic cancer, 6.10 (4.19-8.87, I  = 14%, n = 7) for colorectal cancer (CRC), 4.13 (2.99-5.71, I  = 80%, n = 5) for total cancer, 3.55 (2.94-4.28, I  = 46%, n = 5) for all-cause mortality, and 1.57 (0.25-9.69, I  = 79%, n = 2) for cardiovascular disease. Strong positive associations were observed between PSC and risk of CCA, hepatobiliary cancer, liver cancer, gastrointestinal cancer, pancreatic cancer, CRC, total cancer, and all-cause mortality, but not for cardiovascular disease.
  • Publisher: England: Nature Publishing Group
  • Language: English;Norwegian
  • Identifier: ISSN: 2045-2322
    EISSN: 2045-2322
    DOI: 10.1038/s41598-021-90175-w
    PMID: 34017024
  • Source: MEDLINE
    NORA Norwegian Open Research Archives
    PubMed Central
    SWEPUB Freely available online
    ProQuest Central
    DOAJ Directory of Open Access Journals

Searching Remote Databases, Please Wait